MedPath

Gottfried Wilhelm Leibniz Universität Hannover

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

13

Active:0
Completed:9

Trial Phases

3 Phases

Phase 3:1
Phase 4:2
Not Applicable:8

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Not Applicable
8 (72.7%)
Phase 4
2 (18.2%)
Phase 3
1 (9.1%)

Bioavailability of Different n-3 Fatty Acid Formulations

Phase 4
Completed
Conditions
Health
Interventions
Drug: GArTG
Drug: EE
Drug: KPL
First Posted Date
2010-10-05
Last Posted Date
2011-12-07
Lead Sponsor
Gottfried Wilhelm Leibniz Universität Hannover
Target Recruit Count
12
Registration Number
NCT01214278
Locations
🇩🇪

Gottfried Wilhelm leibniz University of Hanover, Hanover, Lower Saxony, Germany

Effects of Omega-3 Fatty Acids on the Human Gene Expression

Phase 4
Completed
Conditions
Healthy
Hyperlipidemia
First Posted Date
2010-03-18
Last Posted Date
2011-12-19
Lead Sponsor
Gottfried Wilhelm Leibniz Universität Hannover
Target Recruit Count
40
Registration Number
NCT01089231
Locations
🇩🇪

Gottfried Wilhelm Leibniz University of Hanover, Hanover, Lower Saxony, Germany

News

No news found
© Copyright 2025. All Rights Reserved by MedPath